As a journal editor, are you tired of hearing the same excuses from authors who are facing allegations of problematic data? If so, you’re not alone. Recently, an editor of the journal Oncogene co-authored an editorial in the journal listing the types of excuses he often hears — and why none of them is valid. … Continue reading “My dog ate the data:” Eight excuses journal editors hear
The director of the Division of Investigative Oversight at the U.S. Office of Research Integrity is leaving the agency. Susan Garfinkel told Retraction Watch that her last day is November 10. She is taking a position as assistant vice president in the Office of Research Compliance at The Ohio State University (OSU). Garfinkel declined to … Continue reading Division director leaving U.S. research watchdog after nearly 15 years
The week at Retraction Watch featured the retraction of a paper from Yale on ketamine and depression, a retraction for Carlo Croce, and a discussion of when a citation may not be enough. Here’s what was happening elsewhere:
This weekend, Carlo Croce had some reprieve from the misconduct accusations that have followed him for years (recently described in a lengthy article in the New York Times) and that have prompted his university to re-open an investigation. On Sunday, he received a prestigious award from the American Association for Cancer Research, honoring his work. But the moment … Continue reading Journals retract paper, flag two others by cancer doc under investigation
This month hasn’t been all bad for Carlo Croce. Despite issuing two corrections and being the subject of a lengthy New York Times article about how he’s dodged misconduct accusations for years (prompting his institution to re-open an investigation), Croce is now the recipient of a prestigious award from the American Association for Cancer Research. In a recent … Continue reading Cancer org bestows award on scientist under investigation
Consider this: Fragments of a PLOS ONE paper overlap with pieces of other publications. The authors used them without credit and without quotation marks. This sounds an awful lot like plagiarism — using PLOS‘s own standards, even. But the journal isn’t calling it plagiarism. They’ve labeled this an instance of “text overlap,” a spokesperson told us, based … Continue reading When does “overlap” become plagiarism? Here’s what PLOS ONE decided
Alfredo Fusco, a cancer researcher in Italy who is facing a criminal investigation for fraud, has had two more papers retracted.
Carlo Croce, a cancer researcher at The Ohio State University who has had 10 papers retracted and at least as many subject to corrections or expressions of concern, has lost another court appeal. Croce brought the case against Purdue University professor David Sanders in 2017 for statements that Sanders had made in stories in The … Continue reading Litigious OSU professor loses appeal in federal defamation case
Carlo Croce may be back in court again — but this time, as a defendant. Last month, Croce lost a defamation suit he filed against David Sanders, a Purdue researcher who was quoted in a 2017 New York Times story about allegations regarding Croce’s work. Croce had already lost an appeal of a related suit … Continue reading Law firm sues OSU cancer researcher for $900,000 in unpaid fees following failed libel suit
Carlo Croce can’t catch a break in court. Yesterday, a Federal U.S. judge ruled against Croce, a cancer researcher at The Ohio State University, in a case Croce had filed against Purdue University professor David Sanders in 2017. As Judge James Graham, of the Southern District of Ohio Eastern Division, writes in the 36-page ruling … Continue reading Cancer researcher loses defamation suit against critic